Member Contact: Greg Plunkett
Position: Managing Director
Industry: Biotech & Pharmaceuticals
Accelagen is a Melbourne based full service clinical research and regulatory affairs contract research organisation (CRO) supporting local and overseas partners navigate a strategic and effective path to marketing approval. We support all aspects of product development, from early laboratory research through to regulatory approval. Our highly experienced team are committed to exhibit a standard of professionalism and dedication that exceed our clients expectations.
Formed in 2010, we have been proud to be part of the acceleration of a new generation of therapeutic product achieve commercial and regulatory milestones, aiding our clients assets become the mainstay of clinical practice. Our extensive network of high quality investigational sites ensure an efficient study start-up and execution.
Our expertise crosses a wide range of therapeutic areas, including oncology, CNS, renal, respiratory, radiopharmaceuticals, gastroenterology, hepatology, ophthalmology, dermatology, infectious diseases, vaccines, biosimilar, rare diseases, Phase 1 first-in-human, plus many more.